Reporting Symposium: Future-ready OTC Reporting

With the industry in a critical transition phase between major regulatory rewrites prompted by regulators emphasis on data accuracy and quality, the first half of this symposium will explore key takeaways from the implementation of updated and upcoming reporting requirements in the EU, UK, Canada, and Hong Kong. The second half of this symposium will look at how the ISDA Digital Regulatory Reporting solution helps firms like J.P. Morgan and BNP Paribas meet compliance objectives.